Plasma Fractionation Market Size And Forecast

Plasma Fractionation Market size was valued at USD 25.04 Billion in 2021 and is projected to reach USD 41.78 Billion by 2030, growing at a CAGR of 5.85% from 2022 to 2030.

The global plasma fractionation is growing at a rapid pace owing to the increasing use of Immunoglobulins in various therapeutic areas, progress in plasma collection (number of plasma collection centers), rising geriatric population, and the growing prevalence of respiratory diseases and alpha-1-antitrypsin deficiency (AATD). The Global Plasma Fractionation Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Plasma Fractionation Market Definition

Plasma is the most crucial liquid component of whole blood, which contains a tremendous concentration of various proteins. Human plasma is a source of many different proteins however, only several of these proteins are beneficial for producing therapeutic plasma products. It is composed principally of water with little amounts of minerals, salts, ions, nutrients, and proteins in solution.

Plasma fractionation is the process of classifying the various components of blood plasma, which in turn is a component of blood collected through blood fractionation. A wide range of life-saving products is obtained after fractionation of plasma such as – coagulation factors, immunoglobulin, protease inhibitors, anticoagulants, albumins, and others for preventing, managing, and treating various life-threatening human injuries and illnesses.

Get | Download Sample Report @ https://www.verifiedmarketresearch.com/download-sample?rid=28925&utm_source=Free&utm_medium=004

The proteins derived from the plasma are principally categorized into three main classes: Immunoglobulin, which is beneficial in the treatment of autoimmune diseases and improving the immune response. Second is clotting factors that are applied in the treatment of blood disorders such as hemophilia. And the last is albumins, which are useful in cases of exhausted albumin levels or during fluid loss. These derived plasma products have therapeutic effects and are applied in the treatment of various blood plasma-related disorders. The plasma fractionation process is chiefly based upon different criteria such as solubility of the products, and their physical and chemical positions such as pH levels, ionic strengths, and temperature, etc.

Global Plasma Fractionation Market Overview

The growing incidences of blood and immune disorders owing to the increasing geriatric population, along with increasing off-label usage of critical plasma products such as albumins, and Immunoglobulins is the major factor driving the growth of the global Plasma Fractionation Market. The rise in the use of immunoglobulins and alpha-1-antitrypsin in areas of medicine across the globe also fuels the growth of the Plasma Fractionation Market.

In the last few years, the diagnosis of various immunological diseases has increased due to technological advancement, which in turn is also expected to drive market growth. Furthermore, numerous advancements in the product by major manufacturers is also one of the major factor contributing to the growth of the Plasma Fractionation Market across the globe.

Enhanced diagnostic facilities, and ease of access to healthcare coupled with increasing incidences and prevalence of chronic diseases across the globe, are some factors responsible for the upcoming demand for plasma-derived products and are anticipated to drive the Plasma Fractionation Market during the forecast period of 2020-2027. The COVID-19 outbreak has urged scientists to experiment with plasma therapy on affected people as there is no vaccine or specific treatment available against these diseases.

Hence the positive result shown by plasma therapy in disease management and recovery will create opportunities for the market over the forecast period. Conversely, factors such as various stringent regulatory landscapes and pricing pressure are expected to restrict the growth of this market over the forecast period. The more high-priced price is due to the increasing raw material cost, cost of products, and inventory used for the generation of plasma-derived proteins.

Global Plasma Fractionation Market: Segmentation Analysis

The Global Plasma Fractionation Market is Segmented on the basis of Product, Application, and Geography.

Plasma Fractionation Market, By Product

• Coagulation Factors
• Immunoglobulins
• Protease Inhibitors
• Anticoagulants
• Albumins
• Others

Ask For Report Details @ https://www.verifiedmarketresearch.com/product/plasma-fractionation-market/?utm_source=Free&utm_medium=004

Based on Product, the market is segmented into Coagulation Factors, Immunoglobulins, Protease Inhibitors, Anticoagulants, Albumins, and Others. The Immunoglobulins segment is valued for the largest share of the Plasma Fractionation Market in 2019. The growth of this segment is attributed to the growing adoption of SCIg and the increasing on- and off-label use of Immunoglobulins for various indications.

Plasma Fractionation Market, By Application

• Hematology
• Hemato-Oncology
• Rheumatology
• Immunology
• Neurology
• Others

Based on Application, the market is segmented into Hematology, Hemato-Oncology, Rheumatology, Immunology, Neurology, and Others. The neurology segment is valued for the largest share. The growth of this segment is attributed to the response of IVIg in a shorter duration than steroids or oral immunosuppressants and its effectiveness in many disorders of the peripheral and central nervous systems.

Plasma Fractionation Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of regional analysis, the Global Plasma Fractionation Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for is estimated as the fastest-growing region for this market followed by Europe and the Asia Pacific. The growth of North America in the global market is attributed to the growing use of Immunoglobulins in many therapeutic areas, the growing geriatric population, and the rising prevalence of respiratory diseases and AATD.

Key Players

The “Global Plasma Fractionation Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), LFB (France), Biotest (Germany), Sanquin (Netherlands), China Biologic Products (UK), and Bio Products Laboratory (UK).

For More Information @ https://www.verifiedmarketresearch.com/download-sample?rid=28925&utm_source=Free&utm_medium=004

About us –

Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. VMR offers insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.

We, at Verified Market Research assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.

Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research

US: +1 (650)-781-4080

UK: +44 (753)-715-0008

APAC: +61 (488)-85-9400

US Toll-Free: +1 (800)-782-1768

Website:-https://www.verifiedmarketresearch.com/

Email: [email protected]

Try Our New Dashboard :-https://www.verifiedmarketresearch.com/dashboard/?utm_source=Free&utm_medium=004